| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.02 | 0.9 |
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | -0.0039 | 0.9 |
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | -0.0026 | 0.9 |
| mRNA | Bicalutamide | FIMM | pan-cancer | AAC | 0.011 | 0.9 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | -0.0037 | 0.9 |
| mRNA | lenalidomide | FIMM | pan-cancer | AAC | -0.011 | 1 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.0024 | 1 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | -0.0039 | 1 |
| mRNA | CGP-082996 | GDSC1000 | pan-cancer | AAC | 0.0037 | 1 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | -0.0023 | 1 |